- Home
- XOMA
XOMA
XOMA Corporation
as 02-20-2025 1:44pm EST
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.
| Founded: | 1981 | Country: | United States |
| Employees: | N/A | City: | EMERYVILLE |
| Market Cap: | 319.3M | IPO Year: | N/A |
| Target Price: | $72.00 | AVG Volume (30 days): | 56.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $21.25 - $35.00 | Next Earning Date: | 03-07-2025 |
| Revenue: | $21,606,000 | Revenue Growth: | 389.82% |
| Revenue Growth (this year): | 511.37% | Revenue Growth (next year): | 26.92% |
Latest XOMA Corporation News
XOMA Breaking Stock News: Dive into XOMA Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
Argus Research
22 days ago
Daily – Vickers Top Buyers & Sellers for 01/29/2025
Argus Research
a month ago
Daily – Vickers Top Buyers & Sellers for 01/06/2025
GlobeNewswire
2 months ago
XOMA Royalty Declares Quarterly Preferred Stock Dividends
MT Newswires
3 months ago
XOMA Royalty Acquires Pulmokine for $20 Million
GlobeNewswire
3 months ago
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio
Zacks
3 months ago
What Makes XOMA Royalty (XOMA) a New Buy Stock
Simply Wall St.
3 months ago
XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
Compare XOMA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XOMA XOMA Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.